Home/Pipeline/RN3161

RN3161

Obesity (INHBE)

IND-EnablingActive

Key Facts

Indication
Obesity (INHBE)
Phase
IND-Enabling
Status
Active
Company

About Rona Therapeutics

A clinical-stage biotech developing long-acting siRNA therapeutics for metabolic and degenerative diseases using proprietary liver and extrahepatic delivery platforms.

View full company profile